
Acquisition · 18 March 2026CureBayRural healthtech platform for diagnostics and medicinescurebay.com ↗
AcquisitionHealthcare & Life Sciences
CureBay acquires Saveo pharma distribution unit to expand rural reach
By Abha Lohia · Editor ·
CureBay: revenue and funding and every story →
Founded 2021
- CureBay operates a full-stack rural healthtech platform connecting clinics with diagnostics and medicine supply chains
- The company acquired Saveo's pharma distribution unit using existing funds to integrate partners across four states
- This move integrates 10,000 Saveo partners into CureBay's 190 clinic network across Karnataka, Telangana, Andhra Pradesh, and Tamil Nadu
What happened
- CureBay has acquired the pharma distribution unit of Saveo.
- This strategic move aims to improve rural healthcare reach in India.
- The acquisition was financed via existing funds without any new capital raise.
- CureBay will integrate 10,000 Saveo partners into its clinic network.
- The expanded network now spans Karnataka, Telangana, Andhra Pradesh, and Tamil Nadu.
- This acquisition strengthens CureBay's position in the fragmented rural healthcare market.
Why it matters
- The Indian rural healthcare market is estimated at $255 million in 2025.
- The sector is projected to grow at a CAGR of 20.52% through 2034.
- CureBay aims to reduce its break-even timeline to 12-15 months in denser markets.
- Integration allows CureBay to leverage existing distribution infrastructure effectively.
The business
- CureBay provides a full-stack platform covering diagnostics, medicines, and referrals.
- It offers consultations priced at ₹100 per session.
- The Kavach subscription costs ₹499 annually for unlimited benefits.
- The company operates in Odisha, Chhattisgarh, and Jharkhand currently.
- It uses a 'circle' model with approximately 50 clinics per four districts.
- CureBay reported revenue of ₹682 million in FY25.
- The annual run rate reached ₹940 million recently.
- The company plans expansion into Bihar and Uttar Pradesh over two years.
The founders
- Priyadarshi Mohapatra founded CureBay.
- He serves as the current CEO of the company.
Who put in money
- Elevar Equity Lead — Led CureBay's Series A round between 2022 and 2024.
- Bertelsmann India Investments Lead — Co-led CureBay's Series B round in May 2025.
- British International Investment Co-Lead — Co-led CureBay's Series B round in May 2025.
In numbers
₹682 millionRevenue FY25 · 2025
₹940 millionAnnual Run Rate · 2025
$255 millionMarket Size 2025
₹100Consultation Price
₹499/yearSubscription Price
What happens next
- CureBay plans to expand into Bihar, eastern Uttar Pradesh, and Madhya Pradesh.
- The company expects to achieve break-even in 12-15 months in new markets.
- Expansion targets include Telangana and Andhra Pradesh over the next two years.
Earlier rounds
- 2022-2024 · Series A · $13.5M · led by Elevar Equity
- May 2025 · Series B · $21M · led by Bertelsmann India Investments
Up against
MedKartiKureNiramai Gramin Health
Words to know
- Full-stack platform
- A comprehensive service offering all necessary components (diagnostics, medicines, referrals) under one system.
- Break-even
- The point where total revenue equals total expenses, resulting in zero net profit or loss.
- Run rate
- A financial metric used to project future income based on current performance levels.
- Circle model
- An operational structure grouping approximately 50 clinics across four districts for efficient management.
The numbers around it
CureBay has 1 funding rounds in StopDown's archive.
| When | Round | Amount | Led by |
|---|---|---|---|
| 22 October 2026 | Pre-Series C | ₹100 Cr | IvyCap Ventures |
Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →
Other articles talking about it
Terms in this story
- Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.
Read next
FundingCureBay raises ₹100 Cr to grow rural clinicsCureBay runs technology-enabled clinics in underserved areas, offering doctor visits, medicines, diagnostic tests and health memberships to rural familiesFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on CureBay → · All startup news on 18 March 2026 →
Is this CureBay? Get your “Featured on StopDown” badge →